Chairman Sheng-ji Yang, "Ethics for Tomorrow"
Prior to commencement, growth rates were well below replacement. We estimate deployment of 1,000,000 units would be necessary to bring birth rates back up to 2.5. Re-investment of suitable units from each batch can negate need for acquiring "wild" units, but will take 10 years at minimum. Enough variety is present that a genetic bottleneck is not expected to become a problem.
The savings on support costs from the removal of extraneous material, combined with the value of trace elements recovered from said material has reduced upkeep and maintenance costs by 17%. Transplantation of extraneous material also offsets costs. Life support equipment remains our most significant cost.
The most successful hormone treatment sped development by an average of 4 weeks, but increased failure rates by 32%, representing an overall reduction in per-year production and is therefore not recommended. Improvements in nutrition and preventative treatments have reduced overall failure rates to 14%.
The savings on support costs from the removal of extraneous material, combined with the value of trace elements recovered from said material has reduced upkeep and maintenance costs by 17%. Transplantation of extraneous material also offsets costs. Life support equipment remains our most significant cost.
The most successful hormone treatment sped development by an average of 4 weeks, but increased failure rates by 32%, representing an overall reduction in per-year production and is therefore not recommended. Improvements in nutrition and preventative treatments have reduced overall failure rates to 14%.
At this point, our primary problem is the assimilation of batches into the population. Adoption rates are not sufficient to handle more than 1% of each batch. State-run communal care and education is cost-prohibitive. A massive influx of youth will cause demographic instability and the exposure of our project will become inevitable.